Glycyrrhizin for prostate cancer before surgery
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a natural substance called glycyrrhizin (found in licorice root) before prostate surgery. It aims to see if it can help control prostate cancer. You would take it for a short time before your planned prostate removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have prostate cancer confirmed by a biopsy
- You are healthy enough to have surgery to remove your prostate
- You are willing to use a barrier contraceptive (like condoms) during the study
- You have not had other cancer treatments in the last 30 days
- You do not have another active cancer or a history of certain heart rhythm problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (BMS-986365) combined with another hormone therapy (degarelix) before radical prostatectomy for high-risk prostate cancer. The goal is to see if this combination helps lower cancer activity before surgery.
This trial studies giving hormone treatment and radiation before prostate surgery to treat high-risk, locally advanced prostate cancer. It aims to improve cancer control by shrinking or controlling the tumor before removing it.
This trial tests giving a new hormone-blocking drug (darolutamide) plus standard hormone therapy before surgery for men with high-risk prostate cancer that has not spread. The goal is to see if this approach improves outcomes.
This study tests an experimental drug called xaluritamig given before surgery for men with localized prostate cancer that is intermediate or high risk. The goal is to see if it can help shrink the cancer before the prostate is removed.
This trial tests whether combining four drugs (chemotherapy, hormone therapy, and a new medicine) before surgery can help men with aggressive prostate cancer. The goal is to shrink tumors and improve outcomes before the prostate is surgically removed.
This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.